Ongoing litigation against AbbVie and Capstone Therapeutics remains a factor, though management provided no specific updates on the proceedings. A $70.3 million annual revenue decrease reflects the ...
Phase 2 third cohort (28 days, 15 mg) generally safe and well toleratedARCT-032 permitted to proceed into 12-week Phase 2 study; dosing to begin H1 2026Cash runway extended into Q2 2028Investor ...
A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.
Panaji: The Goa Board of Secondary and Higher Secondary Education has begun an inquiry after a student complained of malpractice during the ongoing Class XII board exams by a deputy conductor and the ...
LANSING, Mich. (WJRT) - Gov. Gretchen Whitmer signed two bipartisan bills aimed at reducing digital distractions in Michigan classrooms by banning cell phones. Senate Bill 495 and House Bill 4141 ...
Background The pathogenesis of liver fibrosis centres on the activation of hepatic stellate cells (HSCs). Adenosine-to-inosine RNA editing, primarily catalysed by adenosine deaminase acting on RNA1 ...
Since the fatal shooting of Renee Good in Minneapolis, administration officials have defended the use of deadly force, which agency guidelines say should be a last resort. By Hamed Aleaziz and ...
Cells have a remarkable housekeeping system: Proteins that are no longer needed, defective, or potentially harmful are labeled with a molecular "tag" and dismantled in the cellular recycling machinery ...
cDepartment of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China dDepartment of General Surgery, The ...
In a new study, @HopkinsMedicine researchers found a way to build lasting tumor-fighting immunity and prevent cancer recurrence by turning “immune cool” tumors into “immune hot” ones. › In experiments ...
Single-agent CD19 CAR-NK cell therapy achieved a complete response in third-line Waldenstrom macroglobulinemia (WM), a type of non-Hodgkin lymphoma Second patient maintains an ongoing complete ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果